je.st
news
Tag: cancer research
Cancer research UK launches trial for potential new drug that could help immune system fight cancer
2016-02-24 12:41:14| Biotech - Topix.net
Cancer Research UK's Centre for Drug Development , in partnership with Amgen Inc., has launched a new clinical trial to test a drug that could stop a patient's immune system from protecting tumours. Cancer Research UK scientists are studying Amgen's experimental cancer drug, called AMG319, to find out if it removes the defence shield that hides cancer cells from the immune system.
Tags: system
research
potential
trial
Obama to seek $755 million in new funding for cancer research in U.S. budget: White House
2016-02-01 22:54:15| Biotech - Topix.net
President Barack Obama will ask Congress for $755 million in cancer research funding for the National Institutes of Health and the Food and Drug Administration in his 2017 budget request, the White House said on Monday.
Biden bid on cancer research gets boost in spending deal
2015-12-17 00:17:07| Biotech - Topix.net
Vice President Joe Biden's self-described "moonshot" to cure cancer is getting a modest boost from a congressional deal on federal spending. The spending-and-taxes package moving through Congress includes a $2 billion increase for the National Institutes of Health .
Tags: research
deal
bid
cancer
Cancer research into hereditary links could reduce deaths, Irish conference told
2015-10-09 17:39:51| Footwear - Topix.net
Dr Kenneth Offit pictured before speaking at the annual O'Brien science lecture, at the UCD O'Brien centre for science, Dublin. Picture credit; Damien Eagers 8/10/2015 Dr Kenneth Offit, centre speaks to cud President, Professor, Andrew Deeks and Dr Jennifer Westrup, medical director at the beacon hospital before the annual O'Brien science lecture, at the cud O'Brien centre for science, Dublin.
Tags: links
research
told
conference
Merck and MD Anderson Cancer Center Announce Strategic Immuno-Oncology Research Collaboration in Solid Tumors
2015-08-13 14:00:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. & HOUSTON Clinical Trials to Evaluate Mercks KEYTRUDA (pembrolizumab) in Combination with Other Medicines and Treatments Across Multiple Tumor Types KENILWORTH, N.J. & HOUSTON--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and The University of Texas MD Anderson Cancer Center today announced that they have entered into a strategic clinical research collaboration to evaluate Mercks anti-PD-1 therapy, KEYTRUDA (pembrolizumab), in combination with other treatments, such as chemotherapy, radiation therapy and/or novel antitumor medicines. Language: English Contact: Merck Media Relations:Pamela Eisele, 267-305-3558orAn Phan, 908-255-6325orMerck Investor Relations:Justin Holko, 908-740-1879orMD Anderson Media Relations:Ron Gilmore, 713-745-1898Rlgilmore1@mdanderson.org Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: center
research
solid
cancer